Airway Bacteria Quantification Using Polymerase Chain Reaction Combined with Neutrophil and Eosinophil Counts Identifies Distinct COPD Endotypes.

Haemophilus influenzae airway colonisation chronic obstructive pulmonary disease eosinophil eosinophilic inflammation inflammatory endotypes neutrophil neutrophilic inflammation sputum

Journal

Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304

Informations de publication

Date de publication:
27 Sep 2021
Historique:
received: 26 08 2021
revised: 21 09 2021
accepted: 22 09 2021
entrez: 23 10 2021
pubmed: 24 10 2021
medline: 24 10 2021
Statut: epublish

Résumé

Chronic obstructive pulmonary disease (COPD) inflammatory endotypes are associated with different airway microbiomes. We used quantitative polymerase chain reaction (qPCR) analysis of sputum samples to establish the bacterial load upper limit in healthy controls; these values determined the bacterial colonisation prevalence in a longitudinal COPD cohort. Bacteriology combined with sputum inflammatory cells counts were used to investigate COPD endotypes. Sixty COPD patients and 15 healthy non-smoking controls were recruited. Sputum was analysed by qPCR (for At baseline and 6 months, 23.1% and 25.6% of COPD patients were colonised with The prevalence of

Sections du résumé

BACKGROUND BACKGROUND
Chronic obstructive pulmonary disease (COPD) inflammatory endotypes are associated with different airway microbiomes. We used quantitative polymerase chain reaction (qPCR) analysis of sputum samples to establish the bacterial load upper limit in healthy controls; these values determined the bacterial colonisation prevalence in a longitudinal COPD cohort. Bacteriology combined with sputum inflammatory cells counts were used to investigate COPD endotypes.
METHODS METHODS
Sixty COPD patients and 15 healthy non-smoking controls were recruited. Sputum was analysed by qPCR (for
RESULTS RESULTS
At baseline and 6 months, 23.1% and 25.6% of COPD patients were colonised with
CONCLUSIONS CONCLUSIONS
The prevalence of

Identifiants

pubmed: 34680454
pii: biomedicines9101337
doi: 10.3390/biomedicines9101337
pmc: PMC8533560
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : AstraZeneca
ID : ESR-16-11869

Références

Respir Res. 2019 Jun 7;20(1):114
pubmed: 31174538
J Allergy Clin Immunol. 2019 Mar;143(3):1153-1162.e12
pubmed: 30012514
Am J Respir Crit Care Med. 2013 May 15;187(10):1067-75
pubmed: 23491408
Int J Chron Obstruct Pulmon Dis. 2015 Jun 09;10:1075-83
pubmed: 26089657
Allergy. 2019 Jul;74(7):1249-1256
pubmed: 30834543
Eur Respir J. 2005 Aug;26(2):319-38
pubmed: 16055882
Eur Respir J. 1999 Feb;13(2):338-42
pubmed: 10065678
J Allergy Clin Immunol. 2017 Oct;140(4):1181-1184.e7
pubmed: 28506852
Respirology. 2021 Jul;26(7):643-651
pubmed: 33829619
Chest. 2015 Jan;147(1):46-55
pubmed: 25103335
Respir Res. 2014 Sep 14;15:114
pubmed: 25218165
Am J Respir Crit Care Med. 2019 Oct 15;200(8):e70-e88
pubmed: 31613151
Eur Respir J. 2021 Oct 14;58(4):
pubmed: 33766947
Int J Chron Obstruct Pulmon Dis. 2015 Sep 23;10:2009-16
pubmed: 26451098
PLoS One. 2011 Feb 22;6(2):e16384
pubmed: 21364979
Thorax. 2012 Dec;67(12):1075-80
pubmed: 22863758
Respir Res. 2020 Jul 14;21(1):183
pubmed: 32664956
Respir Res. 2010 Jun 15;11:77
pubmed: 20550701
Clin Exp Immunol. 2013 Feb;171(2):117-23
pubmed: 23286938
Chest. 2004 Dec;126(6):1811-4
pubmed: 15596678
J Cell Mol Med. 2021 Feb;25(4):2203-2212
pubmed: 33369092
Respiration. 2012;83(1):36-44
pubmed: 21912093
Respir Res. 2019 Jun 6;20(1):113
pubmed: 31170986
Respir Res. 2020 Nov 1;21(1):289
pubmed: 33131502
Allergy. 2015 Feb;70(2):161-70
pubmed: 25377782
Expert Rev Respir Med. 2013 Jun;7(3):245-57
pubmed: 23734647
Am J Respir Crit Care Med. 2021 Jun 15;203(12):1488-1502
pubmed: 33332995
Eur Respir J. 2016 Apr;47(4):1082-92
pubmed: 26917613
J Cyst Fibros. 2011 Jan;10(1):21-4
pubmed: 20920896
Am J Respir Crit Care Med. 2020 May 1;201(9):1078-1085
pubmed: 31922913
Am J Respir Crit Care Med. 2020 Sep 1;202(5):660-671
pubmed: 32186896
N Engl J Med. 2004 Jun 24;350(26):2645-53
pubmed: 15215480
Am J Respir Crit Care Med. 1998 Oct;158(4):1185-9
pubmed: 9769280
Int J Chron Obstruct Pulmon Dis. 2017 May 22;12:1507-1518
pubmed: 28579769
Thorax. 2017 Oct;72(10):919-927
pubmed: 28432209
Allergy. 2021 Jun;76(6):1861-1864
pubmed: 33206402
Am Rev Respir Dis. 1992 Jun;145(6):1321-7
pubmed: 1595997
Eur Respir J. 2017 Oct 5;50(4):
pubmed: 28982774
PLoS One. 2010 Jan 05;5(1):e8578
pubmed: 20052417
Sci Rep. 2016 Mar 31;6:23745
pubmed: 27030383
Am J Respir Crit Care Med. 2019 May 15;199(10):1195-1204
pubmed: 30592902
Eur Respir J. 2009 Sep;34(3):648-54
pubmed: 19720809
Allergy. 2020 Feb;75(2):370-380
pubmed: 31506971

Auteurs

Augusta Beech (A)

Manchester Academic Health Science Centre, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PL, UK.
Medicines Evaluation Unit, Manchester University NHS Foundation Trust, Manchester M23 9QZ, UK.

Simon Lea (S)

Manchester Academic Health Science Centre, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PL, UK.

Jian Li (J)

Manchester Academic Health Science Centre, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PL, UK.

Natalie Jackson (N)

Medicines Evaluation Unit, Manchester University NHS Foundation Trust, Manchester M23 9QZ, UK.

Alex Mulvanny (A)

Manchester Academic Health Science Centre, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PL, UK.
Medicines Evaluation Unit, Manchester University NHS Foundation Trust, Manchester M23 9QZ, UK.

Dave Singh (D)

Manchester Academic Health Science Centre, Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester M13 9PL, UK.
Medicines Evaluation Unit, Manchester University NHS Foundation Trust, Manchester M23 9QZ, UK.

Classifications MeSH